首页> 外国专利> Gastric-retentive oral controlled drug delivery system with enhanced retention properties

Gastric-retentive oral controlled drug delivery system with enhanced retention properties

机译:具有增强保留特性的胃滞留口服控制药物递送系统

摘要

Drugs that would benefit from sustained release at a controlled rate for an extended period of time in the stomach or upper intestinal tract are formulated in delivery systems that include a water-swellable particulate matrix impregnated with the drug combined with a chemical agent that pharmacologically induces the fed mode in the patient's stomach. By virtue of this combination, the drug can be ingested independently of the timing of the patient's food intake, and the drug matrix will be retained in the patient's stomach as a continuously dispensing reservoir of the drug even though the particulate matrix as ingested is not large enough to be retained in the patient's stomach other than when the stomach is in the fed mode.
机译:在输送系统中配制将受益于在胃或上肠道延长时间段内以受控速率持续释放的药物,该系统包括浸有药物的水溶胀性颗粒基质以及与可药理诱导药物的化学试剂结合的药物。病人胃中的进食模式。通过这种组合,可以独立于患者食物摄取的时间而摄取药物,并且即使摄取的颗粒基质不大,药物基质也将作为连续分配的药物储存在患者的胃中。除了在胃处于进食模式时,足够保留在患者的胃中。

著录项

  • 公开/公告号AU3290397A

    专利类型

  • 公开/公告日1998-01-07

    原文格式PDF

  • 申请/专利权人 DEPOMED INC.;

    申请/专利号AU19970032903

  • 发明设计人 JOHN W. SHELL;

    申请日1997-05-29

  • 分类号A61K9/00;

  • 国家 AU

  • 入库时间 2022-08-22 02:53:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号